KR20040090272A - A Production method of Viscum album Coloratum extract by supercritical extraction - Google Patents
A Production method of Viscum album Coloratum extract by supercritical extraction Download PDFInfo
- Publication number
- KR20040090272A KR20040090272A KR1020030024313A KR20030024313A KR20040090272A KR 20040090272 A KR20040090272 A KR 20040090272A KR 1020030024313 A KR1020030024313 A KR 1020030024313A KR 20030024313 A KR20030024313 A KR 20030024313A KR 20040090272 A KR20040090272 A KR 20040090272A
- Authority
- KR
- South Korea
- Prior art keywords
- extraction
- mistletoe
- extract
- supercritical
- solvent
- Prior art date
Links
- 238000000194 supercritical-fluid extraction Methods 0.000 title claims abstract description 22
- 239000000284 extract Substances 0.000 title abstract description 29
- 241000221013 Viscum album Species 0.000 title abstract description 8
- 238000004519 manufacturing process Methods 0.000 title description 7
- 238000000605 extraction Methods 0.000 claims abstract description 38
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims abstract description 26
- 238000000034 method Methods 0.000 claims abstract description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000001569 carbon dioxide Substances 0.000 claims abstract description 13
- 229910002092 carbon dioxide Inorganic materials 0.000 claims abstract description 13
- 239000006184 cosolvent Substances 0.000 claims abstract description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims abstract description 7
- 238000002156 mixing Methods 0.000 claims abstract description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims abstract description 3
- 235000014066 European mistletoe Nutrition 0.000 claims description 54
- 241000221012 Viscum Species 0.000 claims description 54
- 235000012300 Rhipsalis cassutha Nutrition 0.000 claims description 53
- UREBWPXBXRYXRJ-UHFFFAOYSA-N ethyl acetate;methanol Chemical compound OC.CCOC(C)=O UREBWPXBXRYXRJ-UHFFFAOYSA-N 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 abstract description 10
- 239000002904 solvent Substances 0.000 abstract description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 abstract description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract 3
- 229960004132 diethyl ether Drugs 0.000 abstract 1
- 229940093499 ethyl acetate Drugs 0.000 abstract 1
- 235000019439 ethyl acetate Nutrition 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 description 15
- 201000011510 cancer Diseases 0.000 description 13
- 238000003809 water extraction Methods 0.000 description 11
- 230000001093 anti-cancer Effects 0.000 description 8
- 238000000926 separation method Methods 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 238000004128 high performance liquid chromatography Methods 0.000 description 7
- 238000000638 solvent extraction Methods 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 102000004856 Lectins Human genes 0.000 description 6
- 108090001090 Lectins Proteins 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 239000002523 lectin Substances 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- QJVXKWHHAMZTBY-GCPOEHJPSA-N syringin Chemical compound COC1=CC(\C=C\CO)=CC(OC)=C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 QJVXKWHHAMZTBY-GCPOEHJPSA-N 0.000 description 5
- QJVXKWHHAMZTBY-KSXIZUIISA-N syringin Natural products COc1cc(C=CCO)cc(OC)c1O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O QJVXKWHHAMZTBY-KSXIZUIISA-N 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000003178 anti-diabetic effect Effects 0.000 description 4
- 239000003472 antidiabetic agent Substances 0.000 description 4
- 210000000170 cell membrane Anatomy 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 230000003276 anti-hypertensive effect Effects 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 235000015872 dietary supplement Nutrition 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000006907 apoptotic process Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 235000016213 coffee Nutrition 0.000 description 2
- 235000013353 coffee beverage Nutrition 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 210000000822 natural killer cell Anatomy 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- DMOXQGWDIIINKU-ZBXWUJIGSA-N 76822-96-3 Chemical compound N([C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(O)=O)[C@@H](C)O)[C@@H](C)O)C(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCCN DMOXQGWDIIINKU-ZBXWUJIGSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000001034 Frostbite Diseases 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 101710197072 Lectin 1 Proteins 0.000 description 1
- 241000221040 Loranthaceae Species 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 1
- 244000187664 Nerium oleander Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 241000219492 Quercus Species 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 108090000829 Ribosome Inactivating Proteins Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 241000533293 Sesbania emerus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 241001408665 Timandra griseata Species 0.000 description 1
- 241001530746 Viscaceae Species 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000010426 asphalt Substances 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 239000003560 cancer drug Substances 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 239000002864 coal component Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000003810 ethyl acetate extraction Methods 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- -1 fatty acid esters Chemical class 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000295 fuel oil Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000000091 immunopotentiator Effects 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000013606 potato chips Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 235000000053 special nutrition Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 108010049518 viscotoxin Proteins 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
- A23L2/04—Extraction of juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/10—Gas
- A23V2250/11—Carbon dioxide
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/24—Heat, thermal treatment
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/44—Supercritical state
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Extraction Or Liquid Replacement (AREA)
Abstract
Description
본 발명은 초임계 추출(supercritical extraction)을 이용하여 겨우살이 (Viscum album, Coloratum) 식물체로부터 유효성분을 추출하는 방법에 관한 것으로좀 더 자세히는 열수추출 또는 용매추출보다 추출효율이 우수하고 환경친화적인 초임계 이산화탄소를 추출용매로 하는 초임계 추출방법을 사용하여 추출 후 폐부산물없이 높은 수율로 유효성분을 획득하는 방법에 관한 것이다.The present invention relates to a method of extracting an active ingredient from a mistletoe plant (Viscum album, Coloratum) using supercritical extraction, which is more efficient and more environmentally friendly than hot water extraction or solvent extraction. The present invention relates to a method for obtaining an active ingredient in a high yield without waste by-products after extraction by using a supercritical extraction method using a critical carbon dioxide as an extraction solvent.
일반적으로 겨우살이는 여러 종류의 숙주나무(전나무, 사과나무, 서양 물푸레나무, 떡갈나무, 소나무 등)에 반기생하는 식물로써 현재 지구상에 약 1,400여종 이상이 존재하며 대부분 Viscaceae와 Loranthaceae의 2개 과(科:family)로 분류가 된다(대한민국 특허공보 제1999-0702487호). 긴 타원형의 혁질의 잎을 가지고 꽃은 이른 봄에 지며 과실은 구형으로 대개는 약간 투명한 황록색을 띄며, 열매의 표면에 점액질이 있어 조류의 발에 부착하여 다른 수목에 이식되어 발아한다. 한국, 유럽, 일본, 타이완, 중국, 아프리카 등지에 분포되어 있다.Mistletoe is a half-parasitic plant that grows on many types of host trees (fir, apple, oleander, oak, pine, etc.). Currently, there are more than 1,400 species on earth, and most of them are the two families of Viscaceae and Loranthaceae. : family) (Korean Patent Publication No. 1999-0702487). It has long oval intact leaves with flowers in early spring. Fruits are spherical, usually slightly transparent yellowish green. Mucus is on the surface of the fruit, attaches to the feet of algae and germinates to other trees. It is distributed in Korea, Europe, Japan, Taiwan, China, and Africa.
우리나라에서는 겨우살이를 한방에서 '상기생'이라는 이름의 약재로 통용되어 왔으며 성질이 평(平)하며 맛은 쓰고(苦) 달며(甘) 독이 없고, 힘줄 뼈, 혈맥, 피부를 충실하게 하며 수염과 눈썹을 자라게 하며, 요통, 동맥경화, 동상, 유산방지 등의 치료에 쓰이고 있다(동의보감, 탕액편).In Korea, mistletoe has been commonly used as a medicinal herb called `` above life ''. It has a flat nature, tastes bitter, and has no poison.It has a strong tendon, blood vein, and skin. It is used for the treatment of low back pain, arteriosclerosis, frostbite, and miscarriage prevention.
겨우살이의 영어 이름인 미슬토(mistletoe)는 1917년 독일의 의학자 루돌프 스타이너(Rudolf Steiner)에 의해서 종양 치료 약물로 추천되었으며 스위스의 이타 베그만(Ita Wegmann)박사가 스타이너의 주장을 받아들여 1926년부터 실제적인 임상에 이용하기 시작하였다. 1960년 초에 스위스 알레스 하임의 루카스 병원에서 본격적으로 암 치료에 도입하여 획기적인 성과를 올리게 됨으로써 신약으로 개발되는 계기가 되었으며 현재는 스위스의 루카스 병원, 독일의 외셀브론 병원, 바이오메드 병원, 하벨회외 병원, 프리덴바일러 병원, 튀빙겐의대 부속병원, 하이델부르그의대부속병원, 비텐-헤르데커 대학병원, 오스트리아의 비엔나의대 부속병원 및 중부 유럽의 400여 군데 병원에서 항암치료에 미슬토 요법을 채택하고 있다.Mistletoe's English name, mistletoe, was recommended as a tumor treatment drug by German medical doctor Rudolf Steiner in 1917, and Dr. Ita Wegmann of Switzerland accepted Steiner's claim in 1926. It began to be used for clinical trials. In the early 1960s, Lucas Hospital in Alesheim, Switzerland, was introduced into cancer treatment, resulting in breakthroughs, which led to the development of new drugs. Currently, Lucas Hospital in Switzerland, Osselbronn Hospital in Germany, Biomed Hospital and Havel Society Hospital Mistletoe therapy has been adopted for chemotherapy at Friedenweiler Hospital, Tübingen Medical University Hospital, Heidelberg Medical University Hospital, Witten-Herdecker University Hospital, Vienna Medical University Hospital in Austria and more than 400 hospitals in Central Europe.
미슬토 요법은 국내에서도 여러 대학의 부속병원과 종합병원, 암 전문 클리닉 등에 확산되어 광범위하게 사용되고 있고, 미슬토 요법에 대한 연구논문이 독일의학계에서만 1,300여 편이 발표되었고, 최근 연구가 더욱 활발히 진행되어 1990년 이후 700여 건의 연구 논문이 발표되었으며, 현재 의약품으로써 미국 FDA승인 절차도 진행되고 있다.Mistletoe therapy is widely used in affiliated hospitals, general hospitals, and cancer clinics in various universities in Korea, and more than 1,300 research papers on mistletoe therapy have been published in the German medical community. Since then, more than 700 research papers have been published, and the US FDA approval process is currently in progress.
겨우살이 엑스의 활성은 현재 의학적으로 증명된 논문만 596편이 출판되었고, 주된 효능은 항암, 면역증강, 항고혈압, 항당뇨, 항균활성으로 보고되고 있다.Mistletoe X activity is currently only 596 published medically proven papers, the main efficacy is reported to be anti-cancer, immune enhancement, antihypertensive, anti-diabetic, antibacterial activity.
1920년경부터 암 치료제로 개발되어 임상적으로 사용되어 온 유럽산 겨우살이 (Viscum album, Coloratum)는 부작용이 거의 없으면서 모든 암에 우수한 항암효과를 발휘한다. 이 제제는 암으로 인한 통증의 감소, 방사선 및 화학요법시의 부작용 감소, 암의 소실 및 재발방지, 수명연장 등 암 환자의 삶의 질을 향상시키는 탁월한 효과가 있는 것으로 알려져 있다. 이 제제는 세포사(apoptosis)에 의한 암세포의 살해 및 면역 활성화 등의 작용에 의하여 효과를 발휘하며, 겨우살이 식물체 추출물의 주요성분으로는 강력한 항암성분으로 알려진 렉틴(lectin)Ⅰ,Ⅱ, Ⅲ등의 당단백 성분, 비스코톡신(viscotoxin)등의 폴리펩타이드, 다당체(polysacchride), 알칼로이드(alkaloid), 퀘어세틴(Quercetine)등의 플라보노사이드 등이 보고되고 있다. 겨우살이 성분 중 가장 많은 연구가 이루어진 것은 주된 항암성분으로 알려진 렉틴이다. 겨우살이 렉틴은 B-체인이 세포 표면의 수용체(특정 탄수화물)에 결합하면 A-체인이 세포 내부로 침투하여 진핵세포의 리보좀을 불활성화시켜서 단백질합성을 저해시키는 활성을 나타내는 타입 II 리보좀-불활성 단백질(ribosome-inactivating protein)에 속한다. 겨우살이 렉틴은 암세포의 경우에도 동일한 기전으로 암세포를 살해하는데, 이때 암세포막의 당은 정상세포막의 당과 구조가 달라 렉틴과 친화성이 높아 암세포만 선택적으로 살해하는 것으로 알려져 있다. 또한 겨우살이 렉틴은 면역체계를 자극하는 면역증강효과가 있으며, 종양세포에 대하여 직접, 간접적으로 대응하는 대식세포 및 NK세포의 활성을 증가시킴으로서 종양세포의 성장을 억제하는 것으로 알려져 있다{Cancer Invest2002;20(7-8):1069-1079,J. Ethnopharmacol2002 Dec;83(3):235-240,Immunology2002 Oct;107(2):268-274,Anticancer Res2002 May-Jun;22(3):1399-1407}.European mistletoe (Viscum album, Coloratum), which has been developed and used clinically as a cancer drug since 1920, has almost no side effects and shows excellent anticancer effects on all cancers. This formulation is known to have an excellent effect of improving the quality of life of cancer patients, such as reducing pain caused by cancer, reducing side effects of radiation and chemotherapy, preventing the loss and recurrence of cancer, and extending life. This agent is effective by killing cancer cells and apoptosis by apoptosis. Glycoproteins such as lectin I, II, III, etc., known as potent anticancer ingredients, are the main components of mistletoe plant extract. Component, polypeptides such as viscotoxin, polysacchride, alkaloid, flavonoids such as quercetine and the like have been reported. The most studied of mistletoe components is lectins, the main anticancer component. Mistletoe lectin is a type II ribosome-inactive protein that exhibits the activity of inhibiting protein synthesis by inactivating ribosomes in eukaryotic cells when the B-chain binds to receptors (specific carbohydrates) on the cell surface. ribosome-inactivating protein). Mistletoe lectin kills cancer cells by the same mechanism in the case of cancer cells, but the sugar of the cancer cell membrane is known to selectively kill only cancer cells because of its high affinity with lectins because the sugar structure of the normal cell membrane is different. Mistletoe lectin is also known to inhibit the growth of tumor cells by increasing the activity of macrophages and NK cells that directly and indirectly respond to tumor cells, stimulating the immune system. Cancer Invest 2002; 20 (7-8): 1069-1079, J. Ethnopharmacol 2002 Dec; 83 (3): 235-240, Immunology 2002 Oct; 107 (2): 268-274, Anticancer Res 2002 May-Jun; 22 (3) : 1399-1407}.
또한, 비스코톡신(viscotoxin)등의 펩타이드 성분은 T-세포의 세포독성력을 증강시켜 암세포의 세포막을 용해시킴으로써 괴사를 일으켜 암을 파괴하는 성분이다. 그리고, 다당체 성분은 미슬토 렉틴에 의해 유도된 임파구의 증식에 관여하고 NK세포의 기능을 활성화시킴으로써 항암효과를 나타내는 것으로 알려져 있다. 이 외에도 알칼로이드, 퀘어세틴 등의 플라보노사이드 성분 등이 함유되어 있어 미슬토 요법은 유럽에서 가장 효과가 확실하고 안전한 치료법으로 인식되고 있다.In addition, a peptide component such as biscotoxin is a component that causes necrosis by destroying cancer cell membranes by enhancing the cytotoxicity of T-cells and dissolving the cell membranes of cancer cells. In addition, the polysaccharide component is known to exhibit anticancer effects by participating in the proliferation of lymphocytes induced by mistletoe lectin and activating the function of NK cells. In addition, flavonosides such as alkaloids and quercetin are included, so mistletoe therapy is recognized as the most effective and safe treatment in Europe.
국내에서도 이러한 겨우살이 추출물을 이용한 면역증강제 조성물의 개발이 이루어지고 있으며(대한민국 특허공보 제1996-0005732호), 항산화 화장료 및 미백제로의 개발(대한민국 특허공보 제2001-0020355호, 제2001-0020356호) 및 비만조절용 건강보조식품의 개발 및(대한민국 특허공보 제2000-0038820호), 건강보조식품,청량음료, 특수영양식품의 개발도 활발히 이루어지고 있다(대한민국 특허공보 제1996-0007091호). 한국의 산야에 자생하는 한국산 겨우살이는 유럽산의 변종으로, 열매가 백색인 유럽산과는 달리 황색이며 식물의 모양 및 성분에도 유럽산과 차이가 많다. 따라서 한국산 겨우살이의 생리학적 활성은 기존 유럽산의 결과와 무척 다른 것으로 사료된다.In Korea, the development of immunopotentiator composition using the mistletoe extract is being made (Korean Patent Publication No. 1996-0005732), and as an antioxidant cosmetic and a whitening agent (Korean Patent Publication No. 2001-0020355, 2001-0020356). In addition, the development of dietary supplements for obesity control (Korean Patent Publication No. 2000-0038820), and the development of health supplements, soft drinks, special nutrition products (Korean Patent Publication No. 1996-0007091). Korean Mistletoe native to Korea's mountains and mountains is a variety of European varieties. Unlike Europeans whose fruits are white, yellow is yellow and the shape and composition of plants differs from European ones. Therefore, the physiological activity of Korean mistletoe seems to be very different from that of existing European.
겨우살이로부터 유효성분을 추출하는 방법으로는 채취된 겨우살이를 증류수로 세척한 후 -80 에서 동결한 후 세절한 후 블렌더(blender)에서 다시 분쇄하고 0.15M NaCl 용액으로 8~12시간동안 4 에서 추출하고 원심분리를 통하여 상등액을 회수한 후 암모늄 설페이트(ammonium sulfate)침전을 통하여 단백질 부분을 회수하고 최소부피의 0.15M NaCl이 함유된 인산완충용액(PBS)에 재현탁시킨 후, 동일한 용액에서 24시간 동안 완충용액을 바꿔가면서 투석시킨 후 세파로즈(Sepharose) 4B를 충진한 컬럼을 이용하여 정제하는 방법(대한민국 특허공보 제1999-0041288호), 건조된 겨우살이를 탄소수 1~3의 무수 또는 함수 알코올, 또는 에틸 아세테이트로 4~30 에서 3~20일간 추출한 다음, 농축하여 제조하는 방법(대한민국 특허공보 제2001-0020356호), 겨우살이 건조물에 물, 탄소수 1~3의 무수 또는 함수 알코올, 또는 에틸 아세테이트로 50~100 에서 3~24시간 동안 추출한 다음, 농축하여 제조하는 방법(대한민국 특허공보 제2001-0020355호)등이 알려져 있다. 그러나 이 모든 방법은 수용액 혹은 유기용제를 사용하는 방법으로써 공정 중에 추출용매의 부피가 커 부산물의 생성량이 많고 고온에서 조업하므로 단백질 성분(렉틴)의 변성이 일어나는 단점이 있다. 또한 비단백성분의 추출 효율도 낮아 대규모 공정을 통한 겨우살이 엑스 제조에 많은 문제점이 있다.Method of extracting active ingredient from mistletoe is to wash the collected mistletoe with distilled water, freeze it at -80, then cut it and grind it again in a blender, and then extract it at 4 for 8-12 hours with 0.15M NaCl solution. After recovering the supernatant by centrifugation, the protein portion was recovered by ammonium sulfate precipitation and resuspended in a minimal volume of phosphate buffer (PBS) containing 0.15 M NaCl for 24 hours in the same solution. Purification using a column packed with Sepharose 4B after dialysis while changing the buffer solution (Korean Patent Publication No. 1999-0041288), dried mistletoe with anhydrous or hydrous alcohol having 1 to 3 carbon atoms, or Extracted with ethyl acetate for 4 to 30 days for 3 to 20 days, and then concentrated to prepare (Korean Patent Publication No. 2001-0020356), Mistletoe dried water, 1 to 3 carbon atoms Or function is known alcohol, or ethyl acetate extraction method at 50 to 100 for 3 to 24 hours and then concentrated prepared in (Republic of Korea Patent Application No. 2001-0020355 call). However, all these methods use an aqueous solution or an organic solvent, and the volume of the extraction solvent is large during the process, and a large amount of by-products are produced and the protein is denatured due to operation at high temperatures. In addition, the extraction efficiency of non-protein components is low, there are many problems in the production of mistletoe X through a large-scale process.
본 발명에서는 이러한 추출, 정제의 문제점을 해결하고자 초임계 추출법을 이용하였다. 초임계 추출은 초임계 유체가 액체나 가스의 중간적 성질을 가지므로 압력이나 온도 혹은 조성의 변화에 의해 추출능력이나 선택성이 크게 변한다는 것을 근거로 한 분리법이다. 초임계유체로 이산화탄소가 가장 잘 쓰이며, 비교적 저온에서 변성을 일으키지 않고 분리할 수 있으며, 추출제의 잔류가 적기 때문에 맥주 호프(hop)의 추출이나 커피원두의 탈 카페인 공정 등 식품, 의약품의 새로운 추출 분리법으로 널리 사용되고 있다. 그 밖에도 의약품공업에서 효소, 비타민의 정제 및 회수, 동물, 식물에서 약효성분 추출(알칼로이드, 토코페롤 등), 의약품 원료의 농축, 정제, 탈용제, 지방혼합물의 분리 및 정제(글리세라이드, 지방산, 레시친), 효모, 균체 생성물의 추출, 식품공업에서 동물유지의 추출(어유, 간유), 식물유지의 추출(대두유, 해바라기유, 팜유, 코코아, 커피), 식품의 탈지방(튀김, 감자칩, 무지방 녹말), 커피, 차의 카페인 제거, 향신료의 추출, 식물색소의 추출, 식품의 탈색, 탈취, 알코올 음료의 연질화 등과 화장품 향료산업에서 천연향료의 추출, 합성향료의 분리 및 정제, 담배의 니코틴 제거, 화장품 원료의 추출 및 정제(계면활성제, 지방산 에스테르, 모노글리세라이드)와 화학공업에서 탄화수소의 분리(지방족과 방향족의 분리, Naphthene계의 분리, olefin의 분리, n-paraffin과 iso-paraffin의 분리), 유기 합성원료의 정제, 유기용매 수용액의 탈수, 공비화합물의 분리 그리고 에너지 산업에서 석탄성분의 추출, 석탄액화유의 추출, 석유 잔사유에서 아스팔트 및 중금속 제거, 원유 또는 중질유의 경질화, 바이오매스 (Biomass) 알코올의 농축, 탈수 등의 다양한 분야에 초임계 유체 추출방법이 응용되고 있다{Methods in Biotechnology, Vol.4: Natural Products Isolation , R. J. P. Cannell}.In the present invention, a supercritical extraction method was used to solve the problems of such extraction and purification. Supercritical extraction is a separation method based on the fact that supercritical fluids have intermediate properties of liquids or gases, and that the extraction capacity or selectivity is greatly changed by changes in pressure, temperature, or composition. Carbon dioxide is best used as a supercritical fluid and can be separated without causing denaturation at a relatively low temperature. Since there is little residue of extractant, new extraction of food and medicines such as beer hop extraction or de-caffeine processing of coffee beans It is widely used as a separation method. In addition, the pharmaceutical industry purifies and recovers enzymes and vitamins, extracts active ingredients from animals and plants (alkaloids, tocopherols, etc.), concentrates and purify pharmaceutical raw materials, isolates and purifies fat mixtures (glycerides, fatty acids, lecithins). ), Yeast, cell product extraction, animal oil extraction in the food industry (fish oil, liver oil), vegetable oil extraction (soybean oil, sunflower oil, palm oil, cocoa, coffee), defatting food (fried, potato chips, radish) Fatty starch), coffee and tea caffeine removal, spice extraction, plant pigment extraction, food decolorization, deodorization, softening of alcoholic beverages, etc. Removal of nicotine, extraction and purification of cosmetic raw materials (surfactants, fatty acid esters, monoglycerides) and hydrocarbon separation in the chemical industry (aliphatic and aromatic separation, naphthene separation, olefin separation, n-par separation of affin and iso-paraffin), purification of organic synthetic raw materials, dehydration of aqueous solutions of organic solvents, separation of azeotrope compounds and extraction of coal components in the energy industry, extraction of coal liquefied oil, removal of asphalt and heavy metals from petroleum residues, crude oil or Supercritical fluid extraction methods have been applied to various fields such as hardening of heavy oils, concentration of biomass alcohols, and dehydration {Methods in Biotechnology, Vol. 4: Natural Products Isolation, RJP Cannell}.
상기의 문제점을 해결하기 위하여, 본 발명은 겨우살이(Viscum album, coloratum ) 식물체로부터 유효성분을 추출함에 있어 초임계 추출(supercritical extraction)을 사용하여 겨우살이로부터 높은 수율로 유효성분을 추출하는 것을 목적으로 한다.In order to solve the above problems, the present invention aims to extract the active ingredient from the mistletoe in high yield by using supercritical extraction in extracting the active ingredient from the mistletoe (Viscum album, coloratum) plants. .
또한, 본 발명은 기존의 추출 방법에서 사용되는 추출용매의 사용을 줄여 고농도의 추출물을 수득하고 용매 사용의 최소화에 따른 환경친화적인 생산을 목적으로 한다.In addition, the present invention aims to reduce the use of the extraction solvent used in the conventional extraction method to obtain a high concentration of extract and environmentally friendly production by minimizing the use of solvent.
또한, 본 발명은 고농도의 추출물 내에 함유되어 있는 항암, 면역증강, 항고혈압, 항당뇨, 항균활성이 높은 단백 및 비단백 물질을 고농도로 회수하는 것을 목적으로 한다.In addition, an object of the present invention is to recover a high concentration of protein and non-protein substances with high anticancer, immune enhancing, antihypertensive, antidiabetic, antimicrobial activity contained in a high concentration of extract.
도 1은 겨우살이 엑스의 제조를 위한 본 발명의 초임계 추출의 공정도이다.1 is a process diagram of the supercritical extraction of the present invention for the production of mistletoe extract.
도 2는 지표물질인 시린진(syringin)의 표준곡선이다.2 is a standard curve of syringin, an indicator substance.
도 3은 지표물질인 시린진(syringin)의 HPLC 오버랩(overlap) 크로마토그램이다.Figure 3 is an HPLC overlap chromatogram of the indicator syringin.
도 4는 겨우살이 열수추출 엑스의 HPLC 데이터이다.4 is HPLC data of mistletoe hot water extraction X.
도 5는 겨우살이 40%알콜 열수추출 엑스의 HPLC 데이터이다.5 is HPLC data of mistletoe 40% alcohol hot water extraction X.
상기의 목적을 달성하기 위하여, 본 발명은 초임계 추출을 위한 추출기에 잘게 썰은 겨우살이를 넣고, 추출을 위한 공용매로 에탄올(ethanol)을 채우고 반응기를 밀폐하는 단계; 초임계 추출을 위한 초임계 유체로 이산화탄소를 가하는 단계; 추출기의 온도를 추출온도로 가열하는 단계; 추출기의 온도가 원하는 온도에 도달한 후 다시 초임계 유체인 이산화탄소를 주입하여 원하는 압력이 될 때까지 가압하는 단계; 원하는 온도와 압력에 도달 시 초임계유체인 이산화탄소를 주입하면서 유효성분을 추출하고 아웃라인(outlet line)을 통하여 추출물질을 배출하는 단계; 로 구성되는 초임계 유체 추출법을 이용한 겨우살이 엑스를 제조하는 방법을 제공한다In order to achieve the above object, the present invention comprises the step of putting finely chopped mistletoe in the extractor for supercritical extraction, filling the ethanol with a cosolvent for extraction and closing the reactor; Adding carbon dioxide to the supercritical fluid for supercritical extraction; Heating the temperature of the extractor to the extraction temperature; After the temperature of the extractor reaches a desired temperature, injecting carbon dioxide, which is a supercritical fluid, to pressurize until the desired pressure is reached; Extracting the active ingredient while injecting carbon dioxide which is a supercritical fluid upon reaching a desired temperature and pressure, and discharging the extract through an outline line; Provides a method for manufacturing mistletoe x using supercritical fluid extraction consisting of
본 발명은 구성을 다음과 같다.The present invention is as follows.
본 발명은 겨우살이에 이산화탄소 및 공용매를 혼합하고 예열한 후 초임계 추출법을 이용하여 겨우살이 엑스의 제조방법에 관한 것이다.The present invention relates to a method for preparing mistletoe X using supercritical extraction after mixing and preheating carbon dioxide and cosolvent in mistletoe.
또한, 본 발명은 상기 추출이 30~50℃, 100~300기압에서 수행되는 것을 특징으로 하는 초임계 추출법을 이용한 겨우살이 엑스의 제조방법에 관한 것이다.In addition, the present invention relates to a method of manufacturing mistletoe X using the supercritical extraction method characterized in that the extraction is carried out at 30 ~ 50 ℃, 100 ~ 300 atm.
또한, 본 발명은 공용매로 에탄올, 메탄올 에칠아세테이트, 노르말 헥산, 다이에칠에테르 중 한가지 이상을 사용하는 것을 특징으로 하는 초임계 추출법을 이용한 겨우살이 엑스의 제조방법에 관한 것이다.The present invention also relates to a method for preparing mistletoe extract using supercritical extraction, characterized in that at least one of ethanol, methanol ethyl acetate, normal hexane, and die ether is used as a cosolvent.
이하, 실시예를 통하여 본 발명의 구체적인 구성에 대하여 상세히 설명한다. 그러나, 본 발명의 권리범위는 이들 실시예의 기재에만 한정되는 것은 아니다.Hereinafter, the specific configuration of the present invention through the embodiment will be described in detail. However, the scope of the present invention is not limited only to the description of these examples.
<실시예 1: 열수추출>Example 1 Hot Water Extraction
건조된 겨우살이를 잘게 썰은 후 4배수의 증류수를 가하여 현탁한 후, 4시간 열수추출을 통하여 겨우살이 열수추출 엑스를 얻었다. 얻은 겨우살이 엑스를 감압건조하여 43brix%의 농축액을 얻었다. 추출효율의 평가는 겨우살이 추출물의 지표성분으로 시린진을 표준물질로 사용하여 HPLC를 이용, PDA(photo diode array)를 통하여 엑스 내의 지표물질의 함량을 분석함으로써 추출율을 비교하였다. 그 결과 열수추출에 의한 겨우살이 엑스 내의 지표물질인 시린진의 함량은 0.636%였다.The dried mistletoe was finely chopped and suspended by adding 4 times the distilled water, and then the mistletoe hot water extraction X was obtained through hot water extraction for 4 hours. The obtained mistletoe extract was dried under reduced pressure to obtain a concentrate of 43brix%. To evaluate the extraction efficiency, the extraction rate was compared by analyzing the content of the indicator in the extract through PDA (photo diode array) using a syringe using a syringe as a standard component of mistletoe extract as a reference material. As a result, the content of syringin, which is an indicator substance in the mistletoe by hot water extraction, was 0.636%.
<실시예 2: 용매추출>Example 2: Solvent Extraction
건조된 겨우살이를 잘게 썰은 후 10배수의 70% 알콜을 가하여 현탁한 후, 25℃에서 4시간 동안 교반추출하여 겨우살이 엑스를 얻었다. 얻은 추출엑스는 HPLC를 이용, PDA를 통하여 엑스 내의 지표물질인 시린진의 함량으로 추출율을 비교하였다. 그 결과 25℃에서 4시간 동안 70% 알콜 교반추출에 의한 지표물질인 시린진의 함량은 0.189%였다.The dried mistletoe was finely chopped and suspended by adding 70% alcohol of 10-fold. After stirring for 4 hours at 25 ° C., mistletoe X was obtained. The extracted extract was compared with the extraction rate by the content of the syringe, a syringe in the extract content through the PDA using HPLC. As a result, the content of syringe, which is an indicator substance, by stirring extraction of 70% alcohol for 4 hours at 25 ℃ was 0.189%.
<실시예 3: 용매추출+초음파분쇄>Example 3: Solvent Extraction + Ultrasonic Crushing>
실시예 2와 같이 25℃에서 4시간 동안 70% 알콜 교반추출을 수행하고, 소니케이터(branson sonifier 450 sonicator)로 10분간 소니케이션(sonication)을 추가로 실행하였다. 얻은 겨우살이 엑스는 HPLC를 이용, PDA를 통하여 엑스 내의 지표물질인 시린진의 함량으로 추출율을 비교하였다. 그 결과 25℃에서 4시간 동안 70% 알콜 교반추출과 초음파 추출을 수행한 엑스 내의 지표물질인 시린진은 0.212%였다.70% alcohol agitation extraction was performed for 4 hours at 25 ° C. as in Example 2, and a sonication was further performed for 10 minutes with a branch sonifier 450 sonicator. The obtained mistletoe extract was compared with the extraction rate by the content of the syringe, a syringe in the extract content through the PDA using HPLC. As a result, the syringe, which is an indicator of X, was 0.212% at 70 ° C. for 4 hours.
<실시예 4: 열수추출+용매추출>Example 4 Hot Water Extraction + Solvent Extraction>
건조된 겨우살이를 잘게 썰은 후 40% 알콜을 가하여 현탁한 후, 4시간 열수추출을 통하여 겨우살이 열수추출 엑스를 얻었다. 얻은 겨우살이 엑스를 감압건조하여 15brix%의 농축액을 얻었다. 얻은 추출엑스는 HPLC를 이용, PDA를 통하여 엑스내의 지표물질인 시린진(syringin)의 함량으로 추출율을 비교하였다. 그 결과 40%알콜을 첨가하여 열수추출을 통해 얻어진 엑스 내의 지표물질인 시린진은 0.434%였다.The dried mistletoe was finely chopped and suspended with 40% alcohol, and then the mistletoe hot water extract X was obtained through hot water extraction for 4 hours. The obtained mistletoe x was dried under reduced pressure to obtain a 15brix% concentrate. The extracted extract was compared with the extraction rate by the content of syringe (syringin) in the extract through PDA using HPLC. As a result, 0.434% of the syringe, an index substance in X, obtained by adding 40% alcohol was extracted through hot water extraction.
<실시예 5: 초임계추출>Example 5: Supercritical Extraction
건조된 겨우살이를 잘게 썰은 후 500mL의 초임계 추출기에 세절한 겨우살이 100g과 공용매로 에탄올 30g을 채운 후 추출기를 밀폐하고, 초임계 추출용매인 이산화탄소를 추출기의 압력이 100기압이 될 때까지 가압하였다. 가압 후 추출기의 온도를 40℃까지 가열한 후, 추출기에 이산화탄소를 다시 주입하면서 300기압이 될 때까지 가압하였다. 추출기의 조건이 40℃, 300기압에 도달하였을 때 추출기에 이산화탄소를 일정량 주입하면서 추출기의 상층부에 있는 아웃렛라인(outlet line)을 통하여 추출물질을 회수하였다. 추출 결과 1시간 가량까지 추출물의 대부분(90wt%이상)을 회수하였고, 2시간 경과 후 추출물이 나오지 않을 때까지 추출을 실시하고, 추출이 끝난 후 회수된 고농도의 추출액을 HPLC를 이용, PDA를 이용하여 엑스내의 지표물질인 시린진(syringin)의 함량으로 추출율을 비교하였다. 그 결과 이산화탄소를 초임계 유체로 사용한 초임계 추출에 의해 얻어진 지표물질인 시린진의 함량은 0.93%였다.After finely slicing the dried mistletoe, 100 ml of fine mistletoe and 30 g of ethanol with cosolvent were sealed in a 500 mL supercritical extractor, and the extractor was sealed. . After the pressurization, the temperature of the extractor was heated to 40 ° C., and then pressurized until 300 atm while injecting carbon dioxide into the extractor again. When the condition of the extractor reached 40 ℃, 300 atm while extracting a certain amount of carbon dioxide into the extractor was recovered through the outlet line (outlet line) in the upper layer (outlet line). As a result of extraction, most of the extracts (90 wt% or more) were recovered until about 1 hour, and after 2 hours, the extracts were extracted until no extracts were obtained. After extraction, the concentrated extract was recovered using HPLC using PDA. The extraction rate was compared with the content of syringin, a marker in the extract. As a result, the content of syringe, which is an indicator material, obtained by supercritical extraction using carbon dioxide as a supercritical fluid was 0.93%.
하기 표1에 추출 방법에 따른 시린진의 양을 나타냈다. 초임계 추출법에 의한 겨우살이 엑스가 가장 높은 수율을 나타냈다.Table 1 shows the amount of syringes according to the extraction method. Mistletoe x by supercritical extraction yielded the highest yield.
따라서, 본 발명은 초임계 추출방법을 이용하여 높은 수율의 겨우살이 엑스를 얻을 수 있다.Therefore, the present invention can obtain a high yield of mistletoe X using a supercritical extraction method.
또한, 본 발명은 추출용매의 사용을 줄여 고농도의 추출물을 수득하고 용매 사용의 최소화에 따른 환경친화적인 겨우살이 엑스의 제조 방법을 제공할 수 있다.In addition, the present invention can reduce the use of the extraction solvent to obtain a high concentration of the extract and can provide a method for producing environmentally friendly mistletoe X according to minimizing the use of solvent.
또한, 본 발명은 고농도의 추출물 내에 함유되어 있는 항암, 면역증강, 항고혈압, 항당뇨, 항균활성이 높은 단백 및 비단백 물질을 고농도로 회수하여 겨우살이 엑스를 유효성분으로 하는 식품, 음료 및 건강보조식품 등을 제공할 수 있다.In addition, the present invention recovers high concentrations of anti-cancer, immune enhancing, antihypertensive, anti-diabetic, anti-diabetic, high-protein and non-protein substances contained in extracts of high concentration, food, beverage and health supplements with Mistletoe extract as an active ingredient Food and the like.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020030024313A KR20040090272A (en) | 2003-04-17 | 2003-04-17 | A Production method of Viscum album Coloratum extract by supercritical extraction |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020030024313A KR20040090272A (en) | 2003-04-17 | 2003-04-17 | A Production method of Viscum album Coloratum extract by supercritical extraction |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20040090272A true KR20040090272A (en) | 2004-10-22 |
Family
ID=37371426
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020030024313A KR20040090272A (en) | 2003-04-17 | 2003-04-17 | A Production method of Viscum album Coloratum extract by supercritical extraction |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20040090272A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100642526B1 (en) * | 2004-09-16 | 2006-11-03 | 코스맥스 주식회사 | Viscum album extract having anti-inflammatory and anti-oxidative activities, and cosmetic composition comprising the same |
KR100684435B1 (en) * | 2005-09-08 | 2007-02-16 | 주식회사 다원 | Composition comprising the extract of dioscorea quinqueloba and viscum album var. coloratum showing anti-oxidative, anti-aging by anti-lipidperoxidative, anti-inflammatory and discharge of phlegm activity |
KR100852879B1 (en) * | 2007-03-07 | 2008-08-19 | 배광석 | Winter clothes aekgiseu abstraction method |
-
2003
- 2003-04-17 KR KR1020030024313A patent/KR20040090272A/en not_active Application Discontinuation
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100642526B1 (en) * | 2004-09-16 | 2006-11-03 | 코스맥스 주식회사 | Viscum album extract having anti-inflammatory and anti-oxidative activities, and cosmetic composition comprising the same |
KR100684435B1 (en) * | 2005-09-08 | 2007-02-16 | 주식회사 다원 | Composition comprising the extract of dioscorea quinqueloba and viscum album var. coloratum showing anti-oxidative, anti-aging by anti-lipidperoxidative, anti-inflammatory and discharge of phlegm activity |
KR100852879B1 (en) * | 2007-03-07 | 2008-08-19 | 배광석 | Winter clothes aekgiseu abstraction method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2240193B1 (en) | Composition comprising the extracts of lindera obtusiloba for prevention and treatment of cardiovascular diseases | |
JP2020033380A (en) | Anti-aging agent | |
CN101816448B (en) | Fragrant solomonseal rhizome, hawthorn fruit and apple composite beverage and preparation method thereof | |
Zhu et al. | The road to reuse of walnut by-products: A comprehensive review of bioactive compounds, extraction and identification methods, biomedical and industrial applications | |
KR100979251B1 (en) | Jujube beverage and method for manufacturing thereof | |
JP2015127339A (en) | Composition for anti-saccharification | |
EP2260855A1 (en) | Composition containing aqueous extract of ashwaganda leaves as the active ingredient and method of producing the same | |
CN110693025B (en) | Composition with synergistic effect of multifunctional components for reducing blood sugar and application thereof | |
JP2014065683A (en) | Anti-glycation composition | |
CN107417696A (en) | A kind of method that raspberry glycosides and ellagic acid are extracted from raspberry | |
KR102137136B1 (en) | Composition comprising pumpkin hydrolysis extract, amorphophallus paeoniifolius hydrolysis extract, curcuma extract and cacao nibs extract | |
CN107184621A (en) | A kind of extracting method of leaf of Moringa active ingredient and its application | |
CN107019136A (en) | A kind of solid beverage with effect of lowering blood sugar and preparation method thereof | |
EP2240191A2 (en) | Composition comprising the extracts of lysimachia clethroides for prevention and treatment of cardiovascular diseases | |
Lee et al. | Ultrasound-assisted extractions for improving the recovery of phenolics and charantin from bitter melon and for increasing the antioxidant, antidiabetic and anti-obesity activities of its extracts | |
KR20040090272A (en) | A Production method of Viscum album Coloratum extract by supercritical extraction | |
JP2015025008A (en) | Anti-glycation composition | |
Goloshvili et al. | Characterization of grape seed extracts of native to Georgia varieties of Vitis vinifera L | |
KR20030095669A (en) | Isoflavon obtained from natural material, process for preparing the same, and use thereof | |
CN107353273A (en) | The method that cyanidenon and Rubus corchorifolius element are extracted from Rubus corchorifolius | |
JP6607418B2 (en) | Anti-glycation composition | |
JP6190211B2 (en) | PDE3 inhibitor | |
JP6260804B2 (en) | Anti-glycation composition | |
KR100758267B1 (en) | Compositions effective for removing hangover, which contain natural plant extracts | |
KR20140123836A (en) | Method For Preparing Schisandra chinensis Concentrate In Order To Protect Liver Against Alcoholic Hepatotoxicity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |